Evidence map›Paper›PMID 34280238›Full record

ArticlePloS one2021

Viral mapping in COVID-19 deceased in the Augsburg autopsy series of the first wave: A multiorgan and multimethodological approach.

Klaus Hirschbühl, Sebastian Dintner, Martin Beer, Claudia Wylezich, Jürgen Schlegel, Claire Delbridge, Lukas Borcherding, Jirina Lippert, Stefan Schiele, Gernot Müller and 9 more

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. [Minimally invasive autopsies-Methods and limitations].Pathologie (Heidelberg, Germany) · 2026
    Review
  4. Review
  5. Article
  6. Neuropathological features of SARS-CoV-2 delta and omicron variants.Journal of neuropathology and experimental neurology · 2023
    Article
  7. Article
  8. Review
  9. SARS-CoV-2 and neurodegenerative diseases: what we know and what we don't.Journal of neural transmission (Vienna, Austria : 1996) · 2022
    Review
  10. High viral loads: what drives fatal cases of COVID-19 in vaccinees? - an autopsy study.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2022
    Article
  11. Article
  12. Article
  13. First report from the German COVID-19 autopsy registry.The Lancet regional health. Europe · 2022
    Article
  14. Impaired Dendritic Cell Homing in COVID-19.Frontiers in medicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Klaus HirschbühlHematology and Oncology, Medical Faculty, University of Augsburg, Augsburg, Germany.ORCID 0000-0002-4847-7460
Sebastian DintnerGeneral Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, Augsburg, Germany.
Martin BeerInstitute of Diagnostic Virology, Friedrich-Loeffler-Institute, Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany.
Claudia WylezichInstitute of Diagnostic Virology, Friedrich-Loeffler-Institute, Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany.
Jürgen SchlegelDepartment of Neuropathology, School of Medicine, Institute of Pathology, Technical University Munich, Munich, Germany.
Claire DelbridgeDepartment of Neuropathology, School of Medicine, Institute of Pathology, Technical University Munich, Munich, Germany.
Lukas BorcherdingGeneral Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, Augsburg, Germany.
Jirina LippertGeneral Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, Augsburg, Germany.
Stefan SchieleComputational Statistics and Data Analysis, Institute of Mathematics, University of Augsburg, Augsburg, Germany.
Gernot MüllerComputational Statistics and Data Analysis, Institute of Mathematics, University of Augsburg, Augsburg, Germany.
Dimitra MoirakiGeneral Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, Augsburg, Germany.
Oliver SpringAnesthesiology and Operative Intensive Care Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany.
Michael WittmannHematology and Oncology, Medical Faculty, University of Augsburg, Augsburg, Germany.
Elisabeth KlingMicrobiology, Medical Faculty, University of Augsburg, Augsburg, Germany.
Georg BraunDepartment of Gastroenterology, University Hospital Augsburg, Augsburg, Germany.
Thomas KrönckeDiagnostic and Interventional Radiology, Medical Faculty, University of Augsburg, Augsburg, Germany.ORCID 0000-0003-4889-1036
Rainer ClausHematology and Oncology, Medical Faculty, University of Augsburg, Augsburg, Germany.
Bruno MärklGeneral Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, Augsburg, Germany.ORCID 0000-0002-7704-850X
Tina SchallerGeneral Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, Augsburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCOVID-19 is only partly understood, and the level of evidence available in terms of pathophysiology, epidemiology, therapy, and long-term outcome remains limited. During the early phase of the pandemic, it was necessary to effectively investigate all aspects of this new disease. Autopsy can be a valuable procedure to investigate the internal organs with special techniques to obtain information on the disease, especially the distribution and type of organ involvement.

methodsDuring the first wave of COVID-19 in Germany, autopsies of 19 deceased patients were performed. Besides gross examination, the organs were analyzed with standard histology and polymerase-chain-reaction for SARS-CoV-2. Polymerase chain reaction positive localizations were further analyzed with immunohistochemistry and RNA-in situ hybridization for SARS-CoV-2.

resultsEighteen of 19 patients were found to have died due to COVID-19. Clinically relevant histological changes were only observed in the lungs. Diffuse alveolar damage in considerably different degrees was noted in 18 cases. Other organs, including the central nervous system, did not show specific micromorphological alterations. In terms of SARS-CoV-2 detection, the focus remains on the upper airways and lungs. This is true for both the number of positive samples and the viral load. A highly significant inverse correlation between the stage of diffuse alveolar damage and viral load was found on a case and a sample basis. Mediastinal lymph nodes and fat were also affected by the virus at high frequencies. By contrast, other organs rarely exhibited a viral infection. Moderate to strong correlations between the methods for detecting SARS-CoV-2 were observed for the lungs and for other organs.

conclusionsThe lung is the most affected organ in gross examination, histology and polymerase chain reaction. SARS-CoV-2 detection in other organs did not reveal relevant or specific histological changes. Moreover, we did not find CNS involvement.

Indexed as

Viral LoadAgedAged, 80 and overAutopsyCentral Nervous SystemCOVID-19FemaleHumansLungLymph NodesMaleMiddle Aged

Identifiers

PMID34280238
PMCPMC8289110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.